VIVS
VIVS
NASDAQ · Biotechnology

Vivosim Labs Inc

$0.22
0.00 (-1.70%)
As of Sep 28, 10:43 PM ET ·
Analyst Consensus
Strong Sell
7
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 57%
Sell 3 43%
Price Target
Analyst Price Target +12,901.8% upside
Low Target $25.08
Average Target $28.63
High Target $44.18
Current Price $0.22
Current
$0.22
Target
$28.63
$25.08 $28.63 avg $44.18
Scenario Analysis
Bear Case
$25.08
11,289.6%
Low target
Base Case
$28.63
+12,901.8%
Avg target
Bull Case
$44.18
+19,963.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$3.87
-94.3% from high
52-Week Low
$0.22
+1.6% from low
Target vs 52W High
$28.63
+639.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%